Companies

Immunovant, Inc. (IMVT) SEC filings

CIK 0001764013 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 03/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2026FY2025FY2022FY2020
Net income (USD)-107.4 M-66.4 M
Diluted EPS (USD/shares)-2.77-1.71

Latest filings

FiledFormDescriptionPeriod
2026-10-234FORM 42026-10-21
2026-10-094FORM 42026-10-07
2026-10-094FORM 42026-10-07
2026-10-094FORM 42026-10-07
2026-10-054FORM 42026-10-01
2026-09-254FORM 42026-09-23
2026-09-038-K8-K items 5.072026-09-02
2026-08-284FORM 42026-08-28
2026-08-214FORM 42026-08-20
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-0610-Q10-Q2026-06-30
2026-08-068-K8-K items 2.02,9.012026-08-06
2026-07-244FORM 42026-07-24
2026-07-244FORM 42026-07-23
2026-07-244FORM 42026-07-23
2026-07-22ARSARS2026-03-31
2026-07-22DEFA14ADEFA14A
2026-07-22DEF 14ADEF 14A2026-09-02
2026-07-104FORM 42026-07-08
2026-07-104FORM 42026-07-08
2026-07-104FORM 42026-07-08
2026-07-064FORM 42026-07-01
2026-06-264FORM 42026-06-26
2026-06-264FORM 42026-06-26
2026-06-264FORM 42026-06-26

Forms on file (last 1,000): 4 323, 8-K 84, 3 34, 144 26, 10-Q 23, DEFA14A 16, CORRESP 13, UPLOAD 12. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=IMVT (0.002 USD), /gw/filings/filings?ticker=IMVT&form=8-K, /gw/filings/facts?ticker=IMVT&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange